Скачайте изображение (превью) выбрав качество

320x180 480x360 640x480 1280x720

Dr Juan Caro Codón (La Paz University Hospital, Madrid, ES) discusses the findings from the TEMPO-HCM study investigating extended ECG monitoring in hypertrophic cardiomyopathy (HCM) patients.

This was a prospective, observational, multicenter trial that included patients with a diagnosis of hypertrophic cardiomyopathy. Investigators compared the rate of clinically relevant arrhythmias within 30 days vs their first 24 hours with an ECG.

Questions
1. What is the significance of this study and what are the barriers in treating HCM patients?
2. Study design, patient cohort, and outcome measures?
3. Current findings of the study?
4. How should these findings influence practice and guidelines?
5. What are the next steps?

Filmed on-site at EHRA 2023, Barcelona.

Visit Radcliffe Cardiology:

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

Like us on Facebook:
Follow us on Twitter:

Чтобы скачать видео "EHRA 23: TEMPO-HCM: Extended ECG Monitoring in HCM" передвинте ползунок вправо